Protocol - Pain Intensity - Child
This protocol consists of a single interviewer-administered question for children aged 4- to 12-years-old assessing acute pain intensity. The item is measured on an 11-point scale. This protocol was validated in individuals aged 4- to 12-years-old.
The Sickle Cell Disease Pain Working Group notes that numeric rating scales (NRS) can be used for children as young as 8 years. For studies that include older children and a mix of children and adults, the NRS might be preferable to provide continuity.
Permission for Use. Copyright of the Faces Pain Scale-Revised (FPS-R) is held by the International Association for the Study of Pain (IASP) ©2001. This material may be photocopied for non-commercial clinical, educational and research use. For reproduction of the FPS-R in a journal, book, or web page, or for any commercial use of the scale, request permission from International Association for the Study of Pain (IASP) online at www.iasp-pain.org/FPS-R.
Faces Pain Scale - Revised (FPS-R)
The FPS-R shows a set of faces indicating how much pain they are in. The left side shows a face with no pain. From left to right, the faces indicate increasing levels of pain until the far right, which shows a high amount of pain. Each face has a score associated with it.
Personnel and Training Required
The interviewer must be trained to conduct personal interviews with individuals from the general population. The interviewer must be trained and found to be competent (i.e., tested by an expert) at the completion of personal interviews. The interviewer should be trained to prompt respondents further if a "dont know" response is provided.
The PhenX Working Group acknowledges these questions can be administered in a computerized or noncomputerized format (i.e., paper-and-pencil instrument). Computer software is necessary to develop computer-assisted instruments. The interviewer will require a laptop computer or handheld computer to administer a computer-assisted questionnaire.
|Specialized requirements for biospecimen collection||No|
|Average time of greater than 15 minutes in an unaffected individual||No|
Mode of Administration
Children aged 4- to 12-years-old
The Faces Pain Scale-Revised (FPS-R) has been tested and found to be reliable and comparable to established measures of the same content areas. It is quick and easy to administer via paper and pencil or electronically. It captures preschool-aged children. Additionally, it has been validated in chronic, acute, and procedural patient populations.
English, Other languages available at source
Process and Review
Protocol Name from Source
Faces Pain Scale-Revised (FPS-R)
Hicks, C. L., von Baeyer, C. L., Spafford, P. A., van Korlaar, I., & Goodenough, B. (2001). The Faces Pain Scale-Revised: Toward a common metric in pediatric pain measurement. Pain, 93(2), 173-183.
Bieri, D., Reeve, R. A., Champion, D. G., Addicoat, L., & Ziegler, J. B. (1990). The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: Development, initial validation, and preliminary investigation for ratio scale properties. Pain, 41(2), 139-150.
Birnie, K. A., Hundert, A. S., Lalloo, C., Nguyen, C., & Stinson, J. N. (2019). Recommendations for selection of self-report pain intensity measures in children and adolescents: A systematic review and quality assessment of measurement properties. Pain, 160(1), 5-18.
da Silva, F. C., Santos Thuler, L. C., & de Leon-Casasola, O. A. (2011). Validity and reliability of two pain assessment tools in Brazilian children and adolescents. Journal of Clinical Nursing, 20(13-14), 1842-1848.
Gupta, N., Naegeli, A. N., Turner-Bowker, D. M., Flood, E. M., Heath, L. E., Mays, S. M., & Dampier, C. (2016). Cognitive testing of an electronic version of the Faces Pain Scale-Revised with pediatric and adolescent sickle cell patients. The Patient, 9(5), 433-443.
Stinson, J. N., Kavanagh, T., Yamada, J., Gill, N., & Stevens, B. (2006). Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents. Pain, 125(1-2), 143-157.
Tsze, D. S., von Baeyer, C. L., Bulloch, B., & Dayan, P. S. (2013). Validation of self-report pain scales in children. Pediatrics, 132(4), e971-e979.
|Variable Name||Variable ID||Variable Description||dbGaP Mapping|
|PX860402010000||In the past 7 days, how would you rate your more||N/A|
May 18, 2022
This measure assesses the magnitude of pain experienced by an individual.
Pain intensity can impact social interactions, physical and mental health, and overall quality of life. Pain is a commonly occurring symptom that affects individuals with a variety of diseases and conditions, including sickle cell disease.
pain intensity - child, PROMIS® Patient-Reported Outcomes Measurement Information System, PROMIS, National Institutes of Health, NIH, pain, Pain measurement, Pain assessment, sickle cell disease, SCD, type 1 diabetes, asthma, atopic dermatitis
|Protocol ID||Protocol Name|
|860401||Pain Intensity - Adolescent and Adult|
|860402||Pain Intensity - Child|
|860403||Pain Intensity - Toddler|
There are no publications listed for this protocol.